VFA
LJPC

Virtus Fund Advisers’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Virtus Fund Advisers’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$670K Buy
20,812
+13,849
+199% +$453K 0.01% 313
2017
Q3 		$242K Sell
6,963
-433
-6% -$13.9K ﹤0.01% 362
2017
Q2 		$238K Sell
7,396
-220
-3% -$6.3K ﹤0.01% 384
2017
Q1 		$227K Buy
+7,616
New +$194K ﹤0.01% 399

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's LJPC Position: Q4 2017 in Review

Virtus Fund Advisers increased its La Jolla Pharmaceutical Company (LJPC) stake by 199% in Q4 2017, buying an estimated $453K and bringing the position to 20,812 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #313.

Virtus Fund Advisers first reported a position in LJPC in Q1 2017 and has held it in 4 quarters since. 93 funds tracked by Wall St. Rank hold LJPC as of Q4 2017.

  • Virtus Fund Advisers held 20,812 shares of La Jolla Pharmaceutical Company worth $670K as of Q4 2017.
  • Virtus Fund Advisers bought 13,849 La Jolla Pharmaceutical Company shares in Q4 2017, an estimated $453K.
  • La Jolla Pharmaceutical Company made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #313 holding.
  • Virtus Fund Advisers first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and has held it in 4 quarters since.
  • 93 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.